China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.71 Million ≈ $18.54 Million USD) by net assets (CN¥37.38 Billion ≈ $5.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000999 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mianyang Fulin Precision Machining Co Ltd
SHE:300432
0.033x
Rising Nonferrous Metals Share Co Ltd
SHG:600259
0.179x
Western Superconducting Tech Co Ltd
SHG:688122
-0.040x
Thai Airways International Public Company Limited
BK:THAI
0.005x
The People's Insurance Company (Group) of China Limited
F:PIR
0.071x
RTL Group SA
XETRA:RRTL
0.009x
MEG Energy Corp
TO:MEG
0.029x
Hanwha
KO:000880
0.032x

Annual Cash Flow Conversion Efficiency for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 000999 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥25.26 Billion
≈ $3.70 Billion
CN¥4.40 Billion
≈ $644.18 Million
0.174x +0.20%
2023-12-31 CN¥24.26 Billion
≈ $3.55 Billion
CN¥4.22 Billion
≈ $617.58 Million
0.174x +1.45%
2022-12-31 CN¥17.53 Billion
≈ $2.57 Billion
CN¥3.01 Billion
≈ $439.93 Million
0.171x +44.03%
2021-12-31 CN¥15.71 Billion
≈ $2.30 Billion
CN¥1.87 Billion
≈ $273.72 Million
0.119x -24.75%
2020-12-31 CN¥14.06 Billion
≈ $2.06 Billion
CN¥2.22 Billion
≈ $325.44 Million
0.158x +3.34%
2019-12-31 CN¥12.88 Billion
≈ $1.89 Billion
CN¥1.97 Billion
≈ $288.54 Million
0.153x -10.55%
2018-12-31 CN¥11.17 Billion
≈ $1.63 Billion
CN¥1.91 Billion
≈ $279.68 Million
0.171x +11.04%
2017-12-31 CN¥10.12 Billion
≈ $1.48 Billion
CN¥1.56 Billion
≈ $228.33 Million
0.154x -3.45%
2016-12-31 CN¥8.72 Billion
≈ $1.28 Billion
CN¥1.39 Billion
≈ $203.71 Million
0.160x -2.77%
2015-12-31 CN¥7.67 Billion
≈ $1.12 Billion
CN¥1.26 Billion
≈ $184.35 Million
0.164x -3.04%
2014-12-31 CN¥7.00 Billion
≈ $1.02 Billion
CN¥1.18 Billion
≈ $173.32 Million
0.169x -26.61%
2013-12-31 CN¥6.36 Billion
≈ $930.82 Million
CN¥1.47 Billion
≈ $214.73 Million
0.231x +6.15%
2012-12-31 CN¥5.58 Billion
≈ $815.96 Million
CN¥1.21 Billion
≈ $177.33 Million
0.217x +10.39%
2011-12-31 CN¥4.85 Billion
≈ $709.79 Million
CN¥954.90 Million
≈ $139.73 Million
0.197x +3.59%
2010-12-31 CN¥4.46 Billion
≈ $653.19 Million
CN¥848.28 Million
≈ $124.13 Million
0.190x -12.18%
2009-12-31 CN¥3.95 Billion
≈ $578.22 Million
CN¥855.05 Million
≈ $125.12 Million
0.216x -33.85%
2008-12-31 CN¥3.41 Billion
≈ $499.38 Million
CN¥1.12 Billion
≈ $163.36 Million
0.327x +55.83%
2007-12-31 CN¥2.88 Billion
≈ $421.94 Million
CN¥605.30 Million
≈ $88.57 Million
0.210x +25.56%
2006-12-31 CN¥2.55 Billion
≈ $372.44 Million
CN¥425.51 Million
≈ $62.26 Million
0.167x +1652.24%
2005-12-31 CN¥2.39 Billion
≈ $350.07 Million
CN¥22.83 Million
≈ $3.34 Million
0.010x +103.03%
2004-12-31 CN¥2.29 Billion
≈ $334.78 Million
CN¥-719.63 Million
≈ $-105.30 Million
-0.315x -3563.86%
2003-12-31 CN¥3.09 Billion
≈ $452.72 Million
CN¥28.09 Million
≈ $4.11 Million
0.009x -94.69%
2002-12-31 CN¥2.90 Billion
≈ $424.65 Million
CN¥496.12 Million
≈ $72.60 Million
0.171x +228.94%
2001-12-31 CN¥2.95 Billion
≈ $432.00 Million
CN¥153.44 Million
≈ $22.45 Million
0.052x -41.96%
2000-12-31 CN¥2.98 Billion
≈ $436.10 Million
CN¥266.86 Million
≈ $39.05 Million
0.090x +96.98%
1999-12-31 CN¥2.65 Billion
≈ $388.31 Million
CN¥120.63 Million
≈ $17.65 Million
0.045x --

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.72 Billion
CN¥39.08 Billion CNY
Market Cap Rank
#3300 Global
#468 in China
Share Price
CN¥23.48
Change (1 day)
-1.30%
52-Week Range
CN¥23.48 - CN¥32.16
All Time High
CN¥1328.34
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more